Biosergen AB TEMP's next confirmed earnings release is scheduled for November 18, 2026.
| Earnings Date | 11/18/2026 |
As of June 30, 2026, Biosergen AB TEMP has 36.21M shares outstanding.
| Shares Outstanding | 36.21M |
As of June 30, 2026, Biosergen AB TEMP maintains a current ratio of 1.07, meaning it holds 1.1x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.07 |
| Quick Ratio | 0.34 |
These figures cover the twelve months ended June 30, 2026.
| Employee Count | 1.50 |
These figures are as of June 30, 2026. Total book value stands at 704,000.00, with working capital of 703,000.00 providing operational flexibility.
| Cash & Cash Equivalents | 3.23M |
| Net Debt | -3.23M |
| Equity (Book Value) | 704,000.00 |
| Book Value Per Share | 0.02 |
| Working Capital | 703,000.00 |
Already premium?